CD4-CD8- 'Double-negative' cutaneous T-cell lymphomas share common histologic features and an aggressive clinical courseJONES, Dan; VEGA, Francisco; SARRIS, Andreas H et al.The American journal of surgical pathology. 2002, Vol 26, Num 2, pp 225-231, issn 0147-5185Article

Primary cutaneous non-hodgkin's lymphoma of Ann Arbor stage I : Preferential cutaneous relapses but high cure rate with doxorubicin-based therapySARRIS, Andreas H; BRAUNSCHWEIG, Ira; CABANILLAS, Fernando et al.Journal of clinical oncology. 2001, Vol 19, Num 2, pp 398-405, issn 0732-183XArticle

Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemiaTHOMAS, Deborah A; SARRIS, Andreas H; CORTES, Jorge et al.Cancer. 2006, Vol 106, Num 1, pp 120-127, issn 0008-543X, 8 p.Article

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabineROMAGUERA, Jorge E; FAYAD, Luis; SARRIS, Andreas H et al.Journal of clinical oncology. 2005, Vol 23, Num 28, pp 7013-7023, issn 0732-183X, 11 p.Article

Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphomaGOY, Andre; YOUNES, Anas; BROGLIO, Kristine et al.Journal of clinical oncology. 2005, Vol 23, Num 4, pp 667-675, issn 0732-183X, 9 p.Article

Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphomaROMAGUERA, Jorge E; MEDEIROS, L. Jeffrey; DANG, Nan H et al.Cancer. 2003, Vol 97, Num 3, pp 586-591, issn 0008-543X, 6 p.Article

Absence of Epstein-Barr virus in anaplastic large cell lymphoma: A study of 64 cases classified according to World Health Organization criteriaHERLING, Marco; RASSIDAKIS, George Z; JONES, Dan et al.Human pathology. 2004, Vol 35, Num 4, pp 455-459, issn 0046-8177, 5 p.Article

BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferationRASSIDAKIS, George Z; JONES, Dan; LAI, Raymond et al.Journal of pathology. 2003, Vol 200, Num 2, pp 240-248, issn 0022-3417, 9 p.Article

Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphomaRASSIDAKIS, George Z; GOY, Andre; MEDEIROS, L. Jeffrey et al.Clinical cancer research. 2003, Vol 9, Num 6, pp 2213-2220, issn 1078-0432, 8 p.Article

Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasoneSARRIS, Andreas H; YUNFANG JIANG; TSIMBERIDOU, Apostolia M et al.Seminars in oncology. 2002, Vol 29, Num 1, pp 48-55, issn 0093-7754, SUP2Article

An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin diseaseCHRONOWSKI, Gregory M; WILDER, Richard B; TUCKER, Susan L et al.Cancer. 2002, Vol 95, Num 12, pp 2534-2538, issn 0008-543X, 5 p.Conference Paper

Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineageRASSIDAKIS, George Z; SARRIS, Andreas H; HERLING, Marco et al.The American journal of pathology. 2001, Vol 159, Num 2, pp 527-535, issn 0002-9440Article